13F-HR filed by Sofinnova Investments, Inc.
Sofinnova Investments, Inc. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 18:13:09 UTC, with 67 holding rows worth $2,301,502,546.
- Accession
- 0001104659-26-128032
- Filer
- CIK 1631134
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 67 entries on the cover page, a total value of $2,301,502,546 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,301,502,546 with VALUE read as dollars as filed, 13F file number 028-18774. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NATERA INC COM | 632307104 | Stock | 1,550,280 | $640,746,227 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 4,349,551 | $155,170,232 | dollars as filed | |
| iShares Russell 2000 ETF | 464287655 | SHS | 500,000 | $138,945,000 | dollars as filed | put |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 422,375 | $97,788,260 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 2,793,987 | $90,217,840 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 445,906 | $82,220,607 | dollars as filed | |
| SEAPORT THERAPEUTICS INC | 81221K108 | COMMON STOCK | 3,564,871 | $71,903,448 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 1,904,408 | $63,988,109 | dollars as filed | |
| ASTRAZENECA PLC ORD | G0593M107 | ADR | 383,053 | $61,851,568 | dollars as filed | |
| INVESCO QQQ TR | 46090E103 | COM | 75,000 | $55,482,750 | dollars as filed | put |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 1,696,752 | $51,377,651 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 534,538 | $50,896,036 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 43,777 | $50,653,491 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 700,000 | $43,680,000 | dollars as filed | call |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,511,006 | $40,452,307 | dollars as filed | |
| INHIBRX BIOSCIENCES INC | 45720N103 | COM | 391,621 | $39,193,430 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 946,340 | $36,358,383 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 1,627,469 | $35,006,858 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 3,585,506 | $31,480,743 | dollars as filed | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 196,700 | $28,043,519 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 112,879 | $27,851,764 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 1,753,703 | $26,358,156 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 432,695 | $25,961,700 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 329,967 | $20,589,941 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 207,000 | $20,457,810 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 36,491 | $19,774,108 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 621,691 | $19,720,039 | dollars as filed | |
| VERADERMICS INC | 922967104 | COMMON STOCK | 144,054 | $17,463,666 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 330,396 | $16,605,703 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 2,293,788 | $16,262,957 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 626,178 | $16,174,178 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 396,598 | $16,101,879 | dollars as filed | |
| IDEXX LABS INC COM | 45168D104 | Stock | 29,145 | $15,219,228 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 231,628 | $15,162,369 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 1,144,827 | $14,390,475 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 63,002 | $14,230,892 | dollars as filed | |
| FIRST TRACKS BIOTHERAPEUTICS | 337185102 | ORD SHS *A* | 383,588 | $13,594,359 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 217,963 | $13,196,570 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 200,000 | $13,092,000 | dollars as filed | put |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 339,018 | $12,903,025 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 523,673 | $12,416,287 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 300,000 | $12,180,000 | dollars as filed | put |
| ERASCA INC COM | 29479A108 | Stock | 677,041 | $9,925,421 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 150,000 | $9,081,750 | dollars as filed | put |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 110,108 | $8,655,590 | dollars as filed | |
| DAMORA THERAPEUTICS INC | G2646Y104 | COMM STK | 149,197 | $3,174,912 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 119,148 | $2,878,616 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 555,300 | $2,348,919 | dollars as filed | call |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 211,802 | $2,314,996 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 356,224 | $1,838,116 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 46,217 | $1,808,471 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 19,450 | $1,662,586 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 162,380 | $1,604,314 | dollars as filed | |
| PHIBRO ANIMAL HEALTH CORP (CLA | 71742Q106 | CL A COM | 43,216 | $1,544,540 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 107,391 | $1,508,844 | dollars as filed | |
| NEXTCURE INC | 65343E207 | COM NEW | 222,654 | $1,115,497 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 3,703 | $1,078,425 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 80,817 | $870,399 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 312,553 | $851,707 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 209,500 | $773,055 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 31,407 | $686,871 | dollars as filed | |
| Wave Life Sciences Inc. | 94352A104 | COM | 184,825 | $683,853 | dollars as filed | |
| AKTIS ONCOLOGY INC | 01021M104 | COMMON STOCK | 31,605 | $615,349 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702203 | COM NEW | 137,721 | $506,813 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 371,700 | $438,606 | dollars as filed | |
| LISATA THERAPEUTICS INC | 128058302 | COM | 156,460 | $225,302 | dollars as filed | |
| IMAGENEBIO INC | 45175G207 | CMN | 31,884 | $146,029 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-26-128032 | this filing | 2026-11-16 |